📈 The Top Analysis for Gilead Sciences Inc (GILD)

Which is the Better Buy? Gilead Sciences vs Bristol-Myers Squibb
Image

Gilead Sciences and Bristol-Myers Squibb are both major pharmaceutical companies, but which of the two is a better opportunity?

🎯 What is the Current Sentiment for GILD?

The current sentiment is neutral
0 top investors currently rate GILD a buy

🔥 Which Investors Rated GILD a Buy?

💸 Gilead Sciences Inc (GILD) - What is the Conversation?

Check out the top conversations on GILD
Image

General 11/26/2024

GILD, Buy

Gilead Sciences Inc
Return: 22.99%

GILD, Buy

Return: 22.99%

Image

General 11/08/2024

GILD, Buy

Gilead Sciences Inc
Return: 15.06%

GILD, Buy

Return: 15.06%

GILD
Gilead Sciences Inc
Market Cap
$119,691,763,712.00
52 Week High
$100.51
PE Ratio
12.926
52 Week Low
$62.07
EPS
$0.09
Shares Outstanding
1,246,269,952.00
Dividend Yield
3.21%
Dividend Per Share
$3.08
PoweredByInsightfulIR
Resources for Publishers
Resources for New Investors
Stock Selection Guides (SSG) - A New Investor Guide
BetterInvesting™ Resources
Partner Resources
The Top Stock Selection Guide Picks
Understanding the Stock Selection Guide


Utility Stocks - A New Investor Guide
Best Utility Stocks to Invest in


Value Investing - Strategy Basics
Resources
Is Value Investing Right for you?
Implementing a Value Strategy


A Guide to Metaverse Stocks
How to Invest
How the Metaverse Makes Money
Metaverse Investment Analysis


A Guide to Industrial Stocks


A Guide to Finance Stocks


A Guide to Healthcare Stocks
How to Invest
Which is a Better Buy in Healthcare?
Critical Healthcare Stocks Analyzed


A Guide to Material Stocks


A Guide to Telecom Stocks